Empirical Study on Financial Competitiveness of Listed Bio-pharmaceutical Companies in China

机译：中国生物制药上市公司财务竞争力实证研究

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

This paper utilized the factor analysis method to carry on the synthetic evaluation to financial competitiveness of listed bio-pharmaceutical companies, proposed the expansion of input-output and growth potential to improve financial competitiveness and pointed out the development direction of the bio-pharmaceutical companies.

机译：本文运用因子分析法对上市生物制药公司的财务竞争力进行了综合评价，提出了扩大投入产出和增长潜力以提高金融竞争力的方法，并指出了生物制药公司的发展方向。

著录项

来源
《2011 Third International Conference on Multimedia Information Networking and Security》|2011年|p.258-260|共3页
会议地点
作者
Chen Hongming; Xu Si;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类国际互联网;
关键词
Bio-pharmaceutical; factor analysis; financial competitiveness;

机译：生物制药;因子分析;财务竞争力;

相似文献

外文文献
中文文献
专利

1. Empirical Study on Financial Competitiveness of Listed Bio-Pharmaceutical Companies [J] . Hongming Chen, Si Xu Advanced Science Letters . 2012,第Null期

机译：生物制药上市公司财务竞争力实证研究
2. Exploring the impact of government subsidy and R&D investment on financial competitiveness of China’s new energy listed companies: An empirical study [J] . Zhihong Zhu, Zhiwei Zhu, Ping Xu, Energy Reports . 2019,第4期

机译：探索政府补贴和研发投资对中国新能源上市公司财务竞争力的影响：一项实证研究
3. Study on Determinants of Chinese Managers' Crisis Intention under Financial Turbulence: An Empirical Study Based on Chinese Listed Companies [J] . Sheng Zhonglin, He Weida Human Factors and Ergonomics in Manufacturing & Service Industries . 2016,第5期

机译：金融动荡下中国经理人危机意图的决定因素研究：基于中国上市公司的实证研究
4. Empirical Study on Financial Competitiveness of Listed Bio-pharmaceutical Companies in China [C] . Chen Hongming, Xu Si International Conference on Multimedia Information Networking and Security . 2011

机译：中国上市生物制药公司金融竞争力的实证研究
5. 中国双重上市公司a、h股价差影响因素的实证研究 =An Empirical Study on the Influence Factors of Price Difference between A-share and H-share of China's Dual-listed Companies [D] . Wang, Huan. 2019

机译：中国双重上市公司a、h股价差影响因素的实证研究 =An Empirical Study on the Influence Factors of Price Difference between A-share and H-share of China's Dual-listed Companies
6. An Empirical Study on the Equity Performance of Chinas Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies [O] . Rendao Ye, Na An, Yichen Xie, 2021

机译：基于Covid-19大熊猫的股权案件的股权绩效基于主导上市案件的实证研究
7. An empirical study on the financial competitiveness of A-share listed companies in Shanghai stock market under the reform of supply side [O] . Jinlei Yang, Tiantian Sun 2017

机译：供应方改革下上海股票市场股票上市公司金融竞争力的实证研究

Empirical Study on Financial Competitiveness of Listed Bio-pharmaceutical Companies in China

摘要

著录项

相似文献

相关主题

期刊订阅